
Poll|Articles|November 5, 2025
Poll: Has the Shortage of IV Ativan Impacted Your Practice?
Author(s)Psychiatric Times Editors
Listen
0:00 / 0:00
Key Takeaways
- The shortage of IV Ativan poses challenges in managing psychiatric conditions, particularly catatonia, necessitating alternative treatment strategies.
- Increased incidences of catatonia may occur due to the difficulty in accessing IV Ativan, impacting patient care.
Answer our poll!
Advertisement
Psychiatric Times contributors have noted a challenge in their psychiatric practice: the shortage of intravenous (IV) Ativan.
Has the shortage of IV Ativan impacted your practice?
Have you noticed an increase in catatonia amongst your patients?
If you have noticed an increase in catatonia or a difficulty in accessing IV Ativan, reach out to us at
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Making Sense of the New Alzheimer Treatment Landscape, With Aaron Ritter, MD
2
What's New in Psychiatric Treatment? Highlights From the 2026 Southern California Psychiatry Conference
3
Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia
4
Preventing Alzheimer Disease After Brain Injury: Targeting TNF With XPro1595
5










